Cas:1808-26-0 Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate manufacturer & supplier

We serve Chemical Name:Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate CAS:1808-26-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate

Chemical Name:Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate
CAS.NO:1808-26-0
Synonyms:Ethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate;5,8,11,14-Eicosatetraenoic acid ethyl ester,Arachidonic acid ethyl ester;Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate;5,8,11,14-Eicosatetraenoic acid, ethyl ester, (all-Z)-;MFCD00038340;5,8,11,14-Eicosatetraenoic acid ethyl ester Arachidonic acid ethyl ester;EINECS 217-314-0;Ethyl Arachidonate;5,8,11,14-Eicosatetraenoic acid, ethyl ester, (5Z,8Z,11Z,14Z)-;ARACHIDONIC ACID ETHYL ESTER
Molecular Formula:C22H36O2
Molecular Weight:332.520
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:418.1±34.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.485
PSA:26.30000
Exact Mass:332.271515
LogP:8.00

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:2845
Packing Group:I


Contact us for information like Ethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ARACHIDONIC ACID ETHYL ESTER physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00038340 Use and application,5,8,11,14-Eicosatetraenoic acid ethyl ester Arachidonic acid ethyl ester technical grade,usp/ep/jp grade.


Related News: In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate manufacturer The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate supplier “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate vendor The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. Ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate factory In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks.